Darwin Global Management, Ltd.
- SEC CIK
- 0001839209
- Latest filing
- Aug 14, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 14, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 3
- 0 vs. Q2 2023
- Portfolio value
- $284.2M
- −$327.5M (−53.5%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 16,688,636 | $191.9M | 67.5% | 00.0% | Unchanged | History |
| IMVTImmunovant, Inc. | COM | 1,818,371 | $69.8M | 24.6% | +1,818,371 | New | History |
| ARGXArgenx SE | SPONSORED ADR | 45,615 | $22.4M | 7.9% | −227,728−83.3% | Reduced | History |
Sold out since Q2 2023 (1)
Positions held at the end of Q2 2023 that are gone from this filing.